Current paradigm of the 18-kDa translocator protein (TSPO) as a molecular target for PET imaging in neuroinflammation and neurodegenerative diseases

被引:0
|
作者
Ching, Alex Sik Chung [1 ]
Kuhnast, Bertrand [1 ]
Damont, Annelaure [1 ]
Roeda, Dirk [1 ]
Tavitian, Bertrand [1 ]
Dolle, Frederic [1 ]
机构
[1] Serv Hosp Freder Joliot, CEA, I2BM, 4 Pl Gen Leclerc, F-91401 Orsay, France
来源
INSIGHTS INTO IMAGING | 2012年 / 3卷 / 01期
关键词
TSPO; Translocator protein; Neuroinflammation; Neurodegenerative diseases; Microglial activation; PET ligands;
D O I
10.1007/s13244-011-0128-x
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Neuroinflammation is a process characterised by drastic changes in microglial morphology and by marked upregulation of the 18-kDa translocator protein (TSPO) on the mitochondria. The continual increase in incidence of neuroinflammation and neurodegenerative diseases poses a major health issue in many countries, requiring more innovative diagnostic and monitoring tools. TSPO expression may constitute a biomarker for brain inflammation that could be monitored by using TSPO tracers as neuroimaging agents. From medical imaging perspectives, this review focuses on the current concepts related to the TSPO, and discusses briefly on the status of its PET imaging related to neuroinflammation and neurodegenerative diseases in humans.
引用
收藏
页码:111 / 119
页数:9
相关论文
共 50 条
  • [1] Current paradigm of the 18-kDa translocator protein (TSPO) as a molecular target for PET imaging in neuroinflammation and neurodegenerative diseases
    Alex Sik Chung Ching
    Bertrand Kuhnast
    Annelaure Damont
    Dirk Roeda
    Bertrand Tavitian
    Frédéric Dollé
    [J]. Insights into Imaging, 2012, 3 (1) : 111 - 119
  • [2] IMAGING THE 18-KDA TRANSLOCATOR PROTEIN (TSPO), A MARKER FOR NEUROINFLAMMATION IN ALCOHOLISM
    Damadzic, R.
    Tyler, R. E.
    Kim, S.
    Jung, Y.
    Wiers, C.
    Vendruscolo, L.
    Koob, G.
    Wang, G-J
    Liow, J-S
    Guo, M.
    Goldman, D.
    Volkow, N.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 : 162A - 162A
  • [3] Translocator Protein 18-kDa: A Promising Target to Treat Neuroinflammation-related Degenerative Diseases
    Tremolanti, Chiara
    Germelli, Lorenzo
    Barresi, Elisabetta
    Da Pozzo, Eleonora
    Simorini, Francesca
    Castellano, Sabrina
    Taliani, Sabrina
    Da Settimo, Federico
    Martini, Claudia
    Costa, Barbara
    [J]. CURRENT MEDICINAL CHEMISTRY, 2022, 29 (28) : 4831 - 4861
  • [4] The 18-kDa Translocator Protein PET Tracers as a Diagnostic Marker for Neuroinflammation: Development and Current Standing
    Singh, Priya
    Adhikari, Anupriya
    Singh, Deepika
    Gond, Chandraprakash
    Tiwari, Anjani Kumar
    [J]. ACS OMEGA, 2022, 7 (17): : 14412 - 14429
  • [5] Neuroinflammation in Major Depressive Disorder: A Review of PET Imaging Studies Examining the 18-kDa Translocator Protein
    Gritti, Davide
    Delvecchio, Giuseppe
    Ferro, Adele
    Bressi, Cinzia
    Brambilla, Paolo
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2021, 292 : 642 - 651
  • [6] Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases
    Dupont, Anne-Claire
    Largeau, Berenger
    Ribeiro, Maria Joao Santiago
    Guilloteau, Denis
    Tronel, Claire
    Arlicot, Nicolas
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (04)
  • [7] The 18-kDa translocator protein (TSPO) regulates cellular metabolism in astrocytes
    Robb, J.
    Hammad, N.
    Beall, C.
    Ellacott, K.
    [J]. DIABETIC MEDICINE, 2018, 35 : 55 - 55
  • [8] On the Role of the Translocator Protein (18-kDa) TSPO in Steroid Hormone Biosynthesis
    Papadopoulos, Vassilios
    [J]. ENDOCRINOLOGY, 2014, 155 (01) : 15 - 20
  • [9] Imaging the 18-KDa Translocator Protein, a Marker of Neuroinflammation, in Alcohol Dependence: Findings and Interpretations
    Hillmer, Ansel
    [J]. NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S95 - S95
  • [10] The 18-kDa Translocator Protein as a CNS Drug Target: Finding Our Way Through the Neuroinflammation Fog
    Filiou, Michaela D.
    Banati, Richard B.
    Graeber, Manuel B.
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2017, 16 (09) : 990 - 999